vs
LINDSAY CORP（LNN）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是LINDSAY CORP的1.4倍（$207.3M vs $150.7M），LINDSAY CORP净利率更高（11.0% vs -62.0%，领先73.0%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -6.1%），LINDSAY CORP自由现金流更多（$-15.1M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 1.3%）
林赛公司总部位于美国内布拉斯加州奥马哈市，原名林赛制造公司，核心产品为旗下Zimmatic品牌中心枢轴灌溉系统，此外还生产农业机械、工程机械，以及公路与铁路基础设施设备。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
LNN vs RARE — 直观对比
营收规模更大
RARE
是对方的1.4倍
$150.7M
营收增速更快
RARE
高出32.0%
-6.1%
净利率更高
LNN
高出73.0%
-62.0%
自由现金流更多
LNN
多$85.7M
$-100.8M
两年增速更快
RARE
近两年复合增速
1.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $150.7M | $207.3M |
| 净利润 | $16.5M | $-128.6M |
| 毛利率 | 33.3% | — |
| 营业利润率 | 13.0% | -54.7% |
| 净利率 | 11.0% | -62.0% |
| 营收同比 | -6.1% | 25.9% |
| 净利润同比 | -3.7% | 3.5% |
| 每股收益（稀释后） | $1.54 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LNNRARE
| Q4 25 | $150.7M | $207.3M | ||
| Q3 25 | $149.0M | $159.9M | ||
| Q2 25 | $165.7M | $166.5M | ||
| Q1 25 | $183.8M | $139.3M | ||
| Q4 24 | $160.5M | $164.6M | ||
| Q3 24 | $149.4M | $139.5M | ||
| Q2 24 | $133.7M | $147.0M | ||
| Q1 24 | $146.8M | $108.8M |
净利润LNNRARE
| Q4 25 | $16.5M | $-128.6M | ||
| Q3 25 | $10.8M | $-180.4M | ||
| Q2 25 | $19.5M | $-115.0M | ||
| Q1 25 | $26.6M | $-151.1M | ||
| Q4 24 | $17.2M | $-133.2M | ||
| Q3 24 | $12.7M | $-133.5M | ||
| Q2 24 | $20.4M | $-131.6M | ||
| Q1 24 | $18.1M | $-170.7M |
毛利率LNNRARE
| Q4 25 | 33.3% | — | ||
| Q3 25 | 30.0% | — | ||
| Q2 25 | 32.4% | — | ||
| Q1 25 | 34.0% | — | ||
| Q4 24 | 31.1% | — | ||
| Q3 24 | 30.6% | — | ||
| Q2 24 | 34.8% | — | ||
| Q1 24 | 33.3% | — |
营业利润率LNNRARE
| Q4 25 | 13.0% | -54.7% | ||
| Q3 25 | 7.6% | -106.9% | ||
| Q2 25 | 14.4% | -64.8% | ||
| Q1 25 | 17.5% | -102.6% | ||
| Q4 24 | 13.0% | -74.3% | ||
| Q3 24 | 9.0% | -94.6% | ||
| Q2 24 | 14.9% | -79.1% | ||
| Q1 24 | 15.1% | -151.9% |
净利率LNNRARE
| Q4 25 | 11.0% | -62.0% | ||
| Q3 25 | 7.3% | -112.8% | ||
| Q2 25 | 11.8% | -69.0% | ||
| Q1 25 | 14.5% | -108.5% | ||
| Q4 24 | 10.7% | -80.9% | ||
| Q3 24 | 8.5% | -95.7% | ||
| Q2 24 | 15.2% | -89.5% | ||
| Q1 24 | 12.3% | -156.8% |
每股收益（稀释后）LNNRARE
| Q4 25 | $1.54 | $-1.28 | ||
| Q3 25 | $0.99 | $-1.81 | ||
| Q2 25 | $1.78 | $-1.17 | ||
| Q1 25 | $2.44 | $-1.57 | ||
| Q4 24 | $1.57 | $-1.34 | ||
| Q3 24 | $1.16 | $-1.40 | ||
| Q2 24 | $1.85 | $-1.52 | ||
| Q1 24 | $1.64 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $199.6M | $421.0M |
| 总债务越低越好 | $115.2M | — |
| 股东权益账面价值 | $518.2M | $-80.0M |
| 总资产 | $828.4M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.22× | — |
8季度趋势，按日历期对齐
现金及短期投资LNNRARE
| Q4 25 | $199.6M | $421.0M | ||
| Q3 25 | $250.6M | $202.5M | ||
| Q2 25 | $210.8M | $176.3M | ||
| Q1 25 | $186.7M | $127.1M | ||
| Q4 24 | $194.1M | $174.0M | ||
| Q3 24 | $190.9M | $150.6M | ||
| Q2 24 | $152.7M | $480.7M | ||
| Q1 24 | $150.6M | $112.3M |
总债务LNNRARE
| Q4 25 | $115.2M | — | ||
| Q3 25 | $115.3M | — | ||
| Q2 25 | $115.3M | — | ||
| Q1 25 | $115.4M | — | ||
| Q4 24 | $115.4M | — | ||
| Q3 24 | $115.5M | — | ||
| Q2 24 | $115.5M | — | ||
| Q1 24 | $115.6M | — |
股东权益LNNRARE
| Q4 25 | $518.2M | $-80.0M | ||
| Q3 25 | $532.9M | $9.2M | ||
| Q2 25 | $528.8M | $151.3M | ||
| Q1 25 | $516.4M | $144.2M | ||
| Q4 24 | $488.5M | $255.0M | ||
| Q3 24 | $480.9M | $346.8M | ||
| Q2 24 | $480.0M | $432.4M | ||
| Q1 24 | $483.0M | $140.3M |
总资产LNNRARE
| Q4 25 | $828.4M | $1.5B | ||
| Q3 25 | $840.8M | $1.2B | ||
| Q2 25 | $840.9M | $1.3B | ||
| Q1 25 | $814.2M | $1.3B | ||
| Q4 24 | $771.0M | $1.5B | ||
| Q3 24 | $760.2M | $1.5B | ||
| Q2 24 | $758.1M | $1.6B | ||
| Q1 24 | $765.3M | $1.3B |
负债/权益比LNNRARE
| Q4 25 | 0.22× | — | ||
| Q3 25 | 0.22× | — | ||
| Q2 25 | 0.22× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.24× | — | ||
| Q3 24 | 0.24× | — | ||
| Q2 24 | 0.24× | — | ||
| Q1 24 | 0.24× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-597.0K | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $-15.1M | $-100.8M |
| 自由现金流率自由现金流/营收 | -10.0% | -48.6% |
| 资本支出强度资本支出/营收 | 9.6% | 0.5% |
| 现金转化率经营现金流/净利润 | -0.04× | — |
| 过去12个月自由现金流最近4个季度 | $62.9M | $-472.0M |
8季度趋势，按日历期对齐
经营现金流LNNRARE
| Q4 25 | $-597.0K | $-99.8M | ||
| Q3 25 | $64.0M | $-91.4M | ||
| Q2 25 | $35.0M | $-108.3M | ||
| Q1 25 | $12.3M | $-166.5M | ||
| Q4 24 | $21.6M | $-79.3M | ||
| Q3 24 | $53.1M | $-67.0M | ||
| Q2 24 | $30.5M | $-77.0M | ||
| Q1 24 | $-9.7M | $-190.7M |
自由现金流LNNRARE
| Q4 25 | $-15.1M | $-100.8M | ||
| Q3 25 | $49.8M | $-92.7M | ||
| Q2 25 | $25.7M | $-110.7M | ||
| Q1 25 | $2.5M | $-167.8M | ||
| Q4 24 | $12.5M | $-79.5M | ||
| Q3 24 | $47.7M | $-68.6M | ||
| Q2 24 | $25.8M | $-79.0M | ||
| Q1 24 | $-21.6M | $-193.9M |
自由现金流率LNNRARE
| Q4 25 | -10.0% | -48.6% | ||
| Q3 25 | 33.4% | -58.0% | ||
| Q2 25 | 15.5% | -66.5% | ||
| Q1 25 | 1.4% | -120.5% | ||
| Q4 24 | 7.8% | -48.3% | ||
| Q3 24 | 31.9% | -49.2% | ||
| Q2 24 | 19.3% | -53.7% | ||
| Q1 24 | -14.7% | -178.2% |
资本支出强度LNNRARE
| Q4 25 | 9.6% | 0.5% | ||
| Q3 25 | 9.6% | 0.8% | ||
| Q2 25 | 5.6% | 1.5% | ||
| Q1 25 | 5.3% | 1.0% | ||
| Q4 24 | 5.7% | 0.1% | ||
| Q3 24 | 3.6% | 1.2% | ||
| Q2 24 | 3.6% | 1.4% | ||
| Q1 24 | 8.1% | 3.0% |
现金转化率LNNRARE
| Q4 25 | -0.04× | — | ||
| Q3 25 | 5.92× | — | ||
| Q2 25 | 1.79× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 1.26× | — | ||
| Q3 24 | 4.17× | — | ||
| Q2 24 | 1.50× | — | ||
| Q1 24 | -0.54× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LNN
| Transferred At Point In Time | $133.2M | 88% |
| Infrastructure | $13.4M | 9% |
| Transferred Over Time | $8.0M | 5% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
